DAVITA INC. (DVA) Stock
4 members of Congress disclosed 6 trades in DVA since 2018: 4 purchases and 2 sales, most recently Alan Armstrong (purchase, Mar 27, 2026). 8 of the hedge funds AlphaScala tracks reported DVA in 13F filings for the quarter ended Sep 30, 2026; the largest reported position is Berkshire Hathaway's at $6.43B. Company insiders reported 0 open-market buys and 1 sale on SEC Form 4 in the 90 days to Nov 2, 2026.
Which members of Congress traded DAVITA INC. (DVA)?
Most recent: Alan Armstrong (purchase, Mar 27, 2026); records start Dec 6, 2018.
| Politician | Trade date | Type | Amount |
|---|---|---|---|
| Alan Armstrong R-OK · Senate | 2026-03-27 | purchase | $1k – $15k |
| Julie Johnson D-TX · House | 2025-09-25 | sale | $1k – $15k |
| Julie Johnson D-TX · House | 2025-09-23 | purchase | $1k – $15k |
| Julie Johnson D-TX · House | 2025-09-23 | sale | $1k – $15k |
| Dean Phillips D-MN · House | 2019-02-04 | purchase | $1k – $15k |
| Jerry Moran R-KS · Senate | 2018-12-06 | purchase | $1k – $15k |
From STOCK Act periodic transaction reports. House filings as of Nov 1, 2026. Senate records here end Oct 21, 2026; later Senate trades are not included.
See all DVA political trades →Which hedge funds own DVA?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| Berkshire Hathaway Warren Buffett | 28.88M | $6.43B | -4% |
| D.E. Shaw David Shaw | 641K | $142.57M | +27% |
| Citadel Ken Griffin | 200K | $44.47M | -72% |
| Millennium Management Israel Englander | 77K | $17.15M | +40% |
| Marshall Wace | 37K | $8.21M | +2324% |
| Hussman Investment Trust John Hussman | 19K | $3.31M | NEW |
| Bridgewater Associates Ray Dalio | 11K | $2.45M | -47% |
| Renaissance Technologies Jim Simons (founder) | 6K | $1.42M | -97% |
13F holdings as of Sep 30, 2026
Explore all tracked funds →Are DAVITA INC. insiders buying or selling?
SEC Form 4 filings| Date | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Oct 27, 26 | Berkshire Hathaway Inc | 10%+ Owner | SELL | 382.6K | $69.0M |
| Jul 31, 26 | Berkshire Hathaway Inc | 10%+ Owner | SELL | 183.0K | $36.5M |
SEC Form 4 filings as of Nov 2, 2026
See cluster-buy signals across all tickers →DVA price chart
Powered by TradingViewWhat does DAVITA INC. do?
DaVita Inc. is a leading healthcare provider specializing in kidney care services for patients with chronic kidney failure. The company operates primarily through its US Dialysis and Related Lab Services segment, delivering dialysis treatments at outpatient facilities across the United States, complemented by laboratory services essential for patient monitoring and care management. It also maintains Other-Ancillary Services and Strategic Initiatives, which encompass integrated kidney care solutions and innovative approaches to enhance patient outcomes. DaVita Inc. focuses on transforming care delivery through clinical quality leadership and advancements in kidney health management, serving as a key player in the renal care sector by providing comprehensive services that support patients' quality of life. Headquartered in Denver, Colorado, and founded in 1994, DaVita Inc. stands as the largest provider of kidney care services in the U.S., emphasizing operational excellence in dialysis and ancillary support.